CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Recordati S.p.A.

REC.MI
$11.70BLarge Cap

Next catalyst

Phase 2January 2027

osilodrostat

Cushing's Syndrome

Get an email about REC.MI's next catalysts

Track Recordati S.p.A. (REC.MI) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 2 more upcoming events in our data (Phase 2 readout).See the timeline

Catalyst Timeline

3 upcoming, 1 past

Phase 2Next

osilodrostat Phase 2 Est. Readout

January 2027~osilodrostat15

Estimated primary completion for osilodrostat trial (NCT07104812) in Mild Autonomous Cortisol Secretion. Topline data typically follows completion by weeks to months.

Source
Phase 2

Pasireotide Phase 2 Est. Readout

February 2027~Pasireotide10

Estimated primary completion for Pasireotide trial (NCT06295952) in Prolactin-Producing Pituitary Tumor. Topline data typically follows completion by weeks to months.

Source
Phase 2

LCI699 Phase 2 Est. Readout

Q3 2027~QLCI69912

Estimated primary completion for LCI699 trial (NCT03708900) in Cushing Syndrome. Topline data typically follows completion by weeks to months.

Source

Market Overview

Stock performance and key metrics

Euronext MilanPharmaceutical Preparations🇮🇹EuropeMilan4.7K employees
Drug Pipeline

Frequently asked questions

What is in Recordati S.p.A.'s drug pipeline?→

CatalystAlert tracks 16 drug candidates in Recordati S.p.A.'s (REC.MI) pipeline across Phase 3, Phase 2. Its lead program is Mercaptamine (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Recordati S.p.A.'s next FDA catalyst?→

Recordati S.p.A.'s (REC.MI) next tracked catalyst is a Phase 2 readout expected January 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track REC.MI biotech catalysts?→

Add REC.MI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Recordati S.p.A.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply